Biohaven Pharmaceutical Holding Company Ltd.
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
BAILEY GREGORY director
Common Shares 164,031 $71.99 $11,808,756
Option
BERMAN ROBERT officer: Special Projects & Med..
Common Shares 986 $75.07 $74,016
Sale
BERMAN ROBERT officer: Special Projects & Med..
Common Shares 986 $75.07 $74,016
Option
BERMAN ROBERT officer: Special Projects & Med..
Employee Stock Option (right to buy) 986 $75.07 $74,016
Option
BERMAN ROBERT officer: Special Projects & Med..
Common Shares 61,314 $3.11 $190,380
Option
BERMAN ROBERT officer: Special Projects & Med..
Employee Stock Option (right to buy) 61,314 $3.11 $190,380
Sale
BERMAN ROBERT officer: Special Projects & Med..
Common Shares 61,314 $75.65 $4,638,527
Option
GENTILE KIMBERLY officer: SVP, Clinical Operations
Employee Stock Option (Right to Buy) 24,000 $5.6 $134,400
Sale
GENTILE KIMBERLY officer: SVP, Clinical Operations
Common Shares 24,000 $5.6 $134,400
Sale
GENTILE KIMBERLY officer: SVP, Clinical Operations
Employee Stock Option (Right to Buy) 400 $5.6 $2,240
Option
GENTILE KIMBERLY officer: SVP, Clinical Operations
Common Shares 24,400 $5.6 $136,640
Sale
DOOGAN DECLAN director
Common Shares 60,000 $68.25 $4,094,760
Sale
DOOGAN DECLAN director
Common Shares 80,000 $66.82 $5,345,520
Option
STOCK ELYSE officer: Chief Medical Officer
Common Shares 36,966 $26.61 $983,480
Option
STOCK ELYSE officer: Chief Medical Officer
Employee Stock Option (Right to Buy) 36,966 $26.61 $983,480
Sale
STOCK ELYSE officer: Chief Medical Officer
Common Shares 36,966 $64.44 $2,382,089
Sale
DOOGAN DECLAN director
Common Shares 80,000 $64.35 $5,148,080
Sale
DOOGAN DECLAN director
Common Shares 80,000 $63.28 $5,062,240
Sale
ENGELHART JAMES officer: Chief Financial Officer
Common Shares 19,772 $63.61 $1,257,598
Option
ENGELHART JAMES officer: Chief Financial Officer
Common Shares 19,772 $9.29 $183,682
Option
ENGELHART JAMES officer: Chief Financial Officer
Employee Stock Option (right to buy) 19,772 $9.29 $183,682
Option
TILTON JOHN officer: Chief Commercial Officer
Common Shares 52,000 $9.29 $483,080
Sale
TILTON JOHN officer: Chief Commercial Officer
Common Shares 52,000 $68.05 $3,538,548
Option
TILTON JOHN officer: Chief Commercial Officer
Employee Stock Option (right to buy) 52,000 $9.29 $483,080
Sale
ENGELHART JAMES officer: Chief Financial Officer
Common Shares 53,953 $67.42 $3,637,457
Option
ENGELHART JAMES officer: Chief Financial Officer
Common Shares 53,953 $5.17 $278,775
Option
ENGELHART JAMES officer: Chief Financial Officer
Employee Stock Option (right to buy) 36,453 $7.45 $271,393
Option
GENTILE KIMBERLY officer: SVP, Clinical Operations
Employee Stock Option (Right to Buy) 600 $5.6 $3,360
Option
GENTILE KIMBERLY officer: SVP, Clinical Operations
Common Shares 600 $5.6 $3,360
Sale
GENTILE KIMBERLY officer: SVP, Clinical Operations
Common Shares 600 $5.6 $3,360
Option
BAILEY GREGORY director
Common Shares 438,200 $11.02 $4,827,211
Option
BAILEY GREGORY director
Stock Option (Right to Buy) 18,000 $28.76 $517,680
Sale
CHILDS JOHN W director
Common Shares 200,000 $32.07 $6,413,800
Sale
CHILDS JOHN W director
Common Shares 150,000 $31.49 $4,723,950
Option
AGUIAR ERIC director
Common Shares 2,021 $34.98 $70,695
Option
AGUIAR ERIC director
Employee Stock Option (Right to Buy) 2,021 $34.98 $70,695
Sale
AGUIAR ERIC director
Common Shares 2,021 $57.17 $115,532
Sale
AGUIAR ERIC director
Common Shares 30,000 $9.29 $278,700
Option
AGUIAR ERIC director
Stock Option (Right to Buy) 30,000 $9.29 $278,700
Option
GENTILE KIMBERLY officer: SVP, Clinical Operations
Employee Stock Option (Right to Buy) 1,590 $29.17 $46,372
Option
GENTILE KIMBERLY officer: SVP, Clinical Operations
Common Shares 1,590 $29.17 $46,372
Option
AGUIAR ERIC director
Common Shares 30,000 $9.29 $278,700
Option
STOCK ELYSE officer: Chief Medical Officer
Restricted Share Unit Award 4,687 $27.96 $131,025
Option
AGUIAR ERIC director
Restricted Share Unit Award 1,250 $55.91 $69,888
Option
AGUIAR ERIC director
Common Shares 1,250 $55.91 $69,888
Option
STOCK ELYSE officer: Chief Medical Officer
Restricted Share Unit Award 937 $55.91 $52,388
Option
STOCK ELYSE officer: Chief Medical Officer
Common Shares 937 $55.91 $52,388
Sale
BERMAN ROBERT officer: Special Projects & Med..
Common Shares 125,000 $54.31 $6,788,750
Option
BERMAN ROBERT officer: Special Projects & Med..
Employee Stock Option (right to buy) 125,000 $0.61 $76,250
Option
BERMAN ROBERT officer: Special Projects & Med..
Common Shares 125,000 $0.61 $76,250

Showing 200 to 250 of 424 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.